| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CNCR.21592 |
| P8608 | Fatcat ID | release_6m2zmxrgtrbhzigdy4m633cy6u |
| P698 | PubMed publication ID | 16333856 |
| P5875 | ResearchGate publication ID | 227606034 |
| P2093 | author name string | Andrew K Stewart | |
| David Ota | |||
| Charles R Thomas | |||
| Anthony Lucci | |||
| Heidi Nelson | |||
| Lisa A Newman | |||
| Cheryl T Lee | |||
| Robert A Beltran | |||
| American College of Surgeons Oncology Group (ACOSOG) Special Population Committee | |||
| Bettye Green | |||
| Lina Patel Parekh | |||
| P2860 | cites work | Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project | Q50134451 |
| Underrepresentation of patients 65 years of age or older in cancer-treatment trials | Q73311140 | ||
| Impact of clinical trials on the cost of cancer care | Q73821541 | ||
| How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials | Q77948975 | ||
| Participation in cancer clinical trials: race-, sex-, and age-based disparities | Q80179103 | ||
| Representation of the elderly, women, and minorities in heart failure clinical trials | Q34769936 | ||
| Selection and description of cancer clinical trials participants--science or happenstance? | Q34810785 | ||
| Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001. | Q35580925 | ||
| Psychopharmacological research ethics: special issues affecting US ethnic minorities | Q35587390 | ||
| Cancer disparities by race/ethnicity and socioeconomic status | Q35733898 | ||
| Why ethnic minority groups are under-represented in clinical trials: a review of the literature | Q35890426 | ||
| Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups | Q35907212 | ||
| Population characteristics of markets of safety-net and non-safety-net hospitals | Q36275114 | ||
| A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. | Q40479199 | ||
| Cost of care for patients in cancer clinical trials | Q41714856 | ||
| Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials | Q43458445 | ||
| Enrollment of African Americans onto clinical treatment trials: study design barriers | Q44376152 | ||
| Including ethnic minorities in mental health intervention research: a practical approach to a long-standing problem | Q44609786 | ||
| Psychosocial treatment research with ethnic minority populations: ethical considerations in conducting clinical trials. | Q45993573 | ||
| Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center | Q46195964 | ||
| Participation in research and access to experimental treatments by HIV-infected patients | Q46500835 | ||
| Cultural competence--marginal or mainstream movement? | Q47322608 | ||
| Willingness to participate in cardiac trials | Q47360325 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 188-195 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee | |
| P478 | volume | 106 |
| Q50055421 | Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the National Cancer Database |
| Q42433234 | Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all |
| Q64101482 | Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast |
| Q38743795 | Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy. |
| Q44443316 | Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group |
| Q35748060 | Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States |
| Q30890572 | Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base |
| Q37476861 | Racial, ethnic and socioeconomic disparities in the treatment of brain tumors |
| Q31142308 | The National Cancer Data Base: a powerful initiative to improve cancer care in the United States |
| Q90115523 | Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer |
| Q38391188 | Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013. |
| Q104072447 | Underrepresented minority representation trends in gynecologic oncology fellowships in the United States |
Search more.